Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Current Leases (2022 - 2026)

TriSalus Life Sciences has reported Current Leases over the past 5 years, most recently at $218000.0 for Q1 2026.

  • For Q1 2026, Current Leases rose 84.75% year-over-year to $218000.0; the TTM value through Mar 2026 reached $218000.0, up 84.75%, while the annual FY2025 figure was $167000.0, 22.69% down from the prior year.
  • Current Leases for Q1 2026 was $218000.0 at TriSalus Life Sciences, up from $167000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $379000.0 in Q3 2023 and troughed at $118000.0 in Q1 2025.
  • A 5-year average of $251916.7 and a median of $242000.0 in 2024 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: tumbled 67.49% in 2025 and later soared 84.75% in 2026.
  • Year by year, Current Leases stood at $370000.0 in 2022, then fell by 5.14% to $351000.0 in 2023, then plummeted by 38.46% to $216000.0 in 2024, then decreased by 22.69% to $167000.0 in 2025, then surged by 30.54% to $218000.0 in 2026.
  • Business Quant data shows Current Leases for TLSI at $218000.0 in Q1 2026, $167000.0 in Q4 2025, and $129000.0 in Q3 2025.